Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Canerpaturev |
| Trade Name | |
| Synonyms | HSV-1 HF10|herpes simplex virus type 1 HF10|HF10 |
| Drug Descriptions |
Canerpaturev (HF10) is a spontaneous herpes simplex virus (HSV) type I mutant variant, which is capable of infecting and lysing tumor cells, and may also lead to non-infected tumor cell death by increasing host immune response (PMID: 31193737). |
| DrugClasses | |
| CAS Registry Number | 1662666-66-1 |
| NCIT ID | C88318 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Canerpaturev | Canerpaturev | 0 | 0 |
| Canerpaturev + Ipilimumab | Canerpaturev Ipilimumab | 0 | 1 |
| Canerpaturev + Nivolumab | Canerpaturev Nivolumab | 0 | 1 |